Company Description
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology.
Its commercial product includes TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis.
It also develops abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for the treatment of hyperphagia related to Prader-Willi syndrome.
Radius Health, Inc. has a partnership with EffRx Pharmaceuticals. Radius Health, Inc. was formerly known as MPM Acquisition Corp. and changed its name to Radius Health, Inc. in May 2011.
The company was incorporated in 2003 and is based in Boston, Massachusetts.
| Country | United States |
| Founded | 2003 |
| IPO Date | Nov 15, 1993 |
| Industry | Steel |
| Sector | Materials |
| Employees | 3,011 |
| CEO | Scott Briggs |
Contact Details
Address: 22 Boston Wharf Road Boston, Delaware 02210 United States | |
| Phone | 617-551-4000 |
| Website | radiuspharm.com |
Stock Details
| Ticker Symbol | RDUS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000912603 |
| CUSIP Number | 806882106 |
| ISIN Number | US8068821060 |
| Employer ID | 93-0341923 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Tamara L. Lundgren J.D. | Chairman, President and Chief Executive Officer |
| Stefano R. Gaggini CPA | Chief Financial Officer and Senior Vice President |
| James Matthew Vaughn J.D. | Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer |
| Steven G. Heiskell | Senior Vice President and President of Products and Services |
| Brian Souza | Senior Vice President, Chief Operations Management Officer and Chief of Ferrous Sales and Trading |
| Marc E. Hathhorn | Chief Operating Officer and Executive Vice President |
| Erika K. Kelley | Chief Accounting Officer and Vice President |
| Michael Bennett | Vice President of Investor Relations |
| Robert Stone | Vice President of Corporate Development |
| Erich D. Wilson | Senior Vice President, Chief Human Resources Officer and Chief of Corporate Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jul 10, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jul 10, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jul 10, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jul 10, 2025 | 25-NSE | Filing |
| Jul 10, 2025 | 8-K | Current Report |
| Jul 7, 2025 | 8-K | Current Report |
| Jul 1, 2025 | 10-Q | Quarterly Report |
| Jul 1, 2025 | 8-K | Current Report |
| Jun 20, 2025 | 8-K | Current Report |